OpGen, Inc. (OPGN) Shows Promising Q1 2023 Results, Surge in After-Market Trading
OpGen, Inc. (OPGN), a leading precision medicine company specializing in molecular diagnostics and bioinformatics for combatting infectious diseases, experienced an impressive surge in after-market trading on Thursday. The stock price soared to $0.7710, reflecting a substantial increase of 24.35%, without any specific catalyst identified. Q1 2023 Financial Results Demonstrate Strong Growth OpGen recently released its […]